Skip to content
Open access

Immunoinformatics-Guided Design and In Silico Evaluation of a Multi-Epitope Vaccine Against Influenza A H10N5 and H3N2 Strains Based on Hemagglutinin and Neuraminidase Proteins

Jul 2026 · bioRxiv · 0 citations
Biology

TL;DR

The immunoinformatics based vaccine design and multi-layered computational validation of a 419-amino-acid multi-epitope subunit vaccine construct targeting conserved hemagglutinin (HA) and neuraminidase (NA) antigens identified through multiple sequence alignment of the avian H10N5 human reference strain sequences are reported.

Read PDF

Similar papers

Open access Oct 2026

Immunoinformatics-based design and in silico evaluation of a multi-epitope vaccine candidate against Naegleria fowleri.

Primary amoebic meningoencephalitis (PAM) is caused by Naegleria fowleri, a free-living amoeba. It is a fatal infection with more than 95% mortality rate. Even though several combinations of antimicrobial agents were used to treat the condition, the overall survival remains poor and no effective vaccine is currently av...

Kadhirmathiyan Velumani, S. Umapathi, Ashwini Malla et al. · 0 citations
Open access Sep 2026

Immunoinformatics-guided design and in silico evaluation of BAFF- and APRIL-adjuvanted multi-epitope vaccine candidates against human metapneumovirus

An immunoinformatics-guided reverse vaccinology approach to design novel BAFF- and APRIL-adjuvanted multi-epitope vaccine candidates against HMPV identified BAFF- and APRIL-containing multi-epitope constructs with favorable predicted antigenic, physicochemical, structural, and immunological characteristics that warrant...

Reham M. Alahmadi, M. Awadalla, Halah Z. AlRawi et al. · 0 citations
Open access Aug 2026

H5N1 influenza multi-epitope vaccine design through immunoinformatics approaches

This study outlines a step-by-step immunoinformatics-driven approach to design a multi-epitope vaccine against H5N1 and leverages a suite of computational tools to accelerate vaccine design by prioritizing promising candidates for experimental validation.

Ankita Singh, Omer S. Alkhnbashi, Filippo Castiglione · 0 citations
#protein folding Open access Oct 2026

A multi-epitope-based DNA vaccine confers cross-protection against influenza A H1N1 and H3N2 viruses

Background and Objectives: Influenza A virus remains a major global health concern because antigenic drift reduces the long-term efficacy of current vaccines. This study evaluated a multi-epitope DNA vaccine targeting conserved regions of hemagglutinin (HA) and polymerase acidic (PA) proteins from influenza A/H1N1 and...

K. Barkhordari, F. Rezaei, V. Salimi et al. · 0 citations
Open access Sep 2026

Immunoinformatics-based design of a multi-epitope mRNA vaccine candidate targeting the major human-infecting hepatitis E virus genotypes 1–4

Background Hepatitis E virus (HEV) is one of the leading causes of acute and chronic hepatitis among humans across the globe and is linked to severe diseases in immunocompromised individuals and pregnant women. Despite its substantial global burden, only one vaccine is licensed (in China and Pakistan), limiting its glo...

Maham Mehrangaze Khonza, Zain Saeed, Zohra Jabeen et al. · 0 citations
Open access Sep 2026

Computational prediction of a multi-epitope Human Metapneumovirus vaccine candidate through integrated reverse vaccinology and pan-genomic approaches

Human metapneumovirus (HMPV) is a primary cause of global respiratory infections yet no approved vaccine currently exists. This study computationally predicts a multi-epitope vaccine candidate using a diverse dataset of 65 HMPV sequences spanning five continents. Following the screening of lead proteins for antigenicit...

N. Alam, Moumita Chakrabarty, Tanmoy Debnath et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.